Kaliumklorid Ps (Potassium Chloride)

After oral intake, potassium chloride dissociates into potassium ions that enter the extracellular fluid. The increase in extracellular potassium drives passive movement of potassium into cells through potassium channels, re‑balancing the intracellular‑extracellular gradient and supporting cellular electrical stability and enzymatic activity.

The prescribed dose of Kaliumklorid Ps is individualized by the treating clinician based on the patient’s current serum potassium level, the severity of the deficiency, renal function, and any concomitant medications. The prescriber sets the exact amount and frequency required for safe correction.

Safety data for potassium chloride in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision. Women who are pregnant or nursing should discuss use with their healthcare provider.

To order Kaliumklorid Ps, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Kaliumklorid Ps provides potassium in the chloride salt form, which is widely used for rapid correction of potassium loss. Compared with potassium gluconate or potassium citrate, the chloride form delivers a higher elemental potassium content per milligram, but may be associated with a slightly higher incidence of gastrointestinal irritation.

Store Kaliumklorid Ps at temperatures below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not store in a refrigerator or freezer unless the manufacturer’s label specifically advises otherwise.

Kaliumklorid Ps is taken orally, usually with a glass of water. The exact dosing schedule—such as single daily doses or divided doses—depends on the prescriber’s instructions, the severity of the potassium deficit, and the patient’s renal function. It should be swallowed whole unless the label indicates a different method.

The most serious risks include hyperkalemia, which can cause life‑threatening cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Patients with impaired kidney function, uncontrolled diabetes, or those taking other potassium‑raising drugs are at higher risk and require close monitoring.

Kaliumklorid Ps should be avoided in individuals with known hyperkalemia, severe renal impairment, or those taking medications that significantly raise potassium levels (e.g., potassium‑sparing diuretics, ACE inhibitors) without appropriate monitoring. It is also contraindicated in patients with a documented hypersensitivity to potassium chloride.